Challenges and progress in the development of a serogroup B meningococcal vaccine.

Serogroup B meningococci cause the majority of the meningococcal disease burden in developed countries. Production of an effective and safe vaccine for serogroup B organisms has been hampered by the poor immunogenicity of the capsular polysaccharide that defines this group of bacteria. Previous effo...

पूर्ण विवरण

ग्रंथसूची विवरण
मुख्य लेखकों: Lewis, S, Sadarangani, M, Hoe, J, Pollard, A
स्वरूप: Journal article
भाषा:English
प्रकाशित: 2009